BRIEF-Biontech And Bristol Myers Squibb Report Encouraging Global Phase 2 Data For Pumitamig In Advanced Nsclc After Progression On Immunotherapy Plus Chemotherapy

Reuters · 10/25 07:31

Please log in to view news